ARCHIVES

FDA Grants Six-Month Priority Review To Nolvadex For DCIS Adjuvant Treatment.

This article is from The Cancer Letter archive.

Vol. 26 No. 13 | March 31, 2000

Download PDF Visit The Full Archive

Related Articles

In Multi-Site Phase I Studies, No Investigator Sees All Toxicities

March 26, 2010

Practice of Oncology Must Incorporate Clinical Research, NCI Director Tells ASCO

May 30, 1997

Lurie Center At Northwestern Wins Core Grant Renewal.

December 7, 2001

In Brief: NIH Appeals Board Restores Nassau CCOP Funding, PI Says It Is Now Meeting Patient Accrual Goal

February 22, 1985

Funding Opportunities

October 18, 2002

NCI Staff Recommends Moving Cooperative Groups Into DCT, Increase Funding, Switch Emphasis

July 4, 1975